Prelude Capital Management, LLC Cytokinetics Inc Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 18,891 shares of CYTK stock, worth $890,710. This represents 0.06% of its overall portfolio holdings.

Number of Shares

18,891

Previous 18,891 -0.0%

Holding current value

$890,710

Previous $997,000 -0.0%

% of portfolio

0.06%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $967,597 - $1.14 Million	18,891 New	18,891 $997,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $270,108 - $457,850	4,237 Added 35.95%	16,023 $1.12 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $56,071 - $174,160	2,086 Added 21.51%	11,786 $984,000
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $18,589 - $23,100	631 Added 6.96%	9,700 $285,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $57,639 - $72,005	1,767 Added 24.2%	9,069 $295,000
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $243,594 - $333,774	7,302 New	7,302 $256,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $283,286 - $531,116	-18,564 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $153,547 - $216,070	7,461 Added 67.2%	18,564 $402,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $96,269 - $212,741	8,634 Added 349.7%	11,103 $262,000
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $47,818 - $89,079	-5,465 Reduced 68.88%	2,469 $29,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $63,075 - $93,938	7,934 New	7,934 $84,000
Q1 2019 May 15, 2019	SELL	$5.95 - $10.19 $1,279 - $2,190	-215 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $1,270 - $1,997	215 New	215 $1,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $301,826 - $433,055	-43,743 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$7.2 - $10.05 $18,684 - $26,079	-2,595 Reduced 5.6%	43,743 $315,000
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $76,371 - $164,857	10,534 Added 29.42%	46,338 $378,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $429,648 - $537,060	35,804	35,804 $519,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Cytokinetics Inc Transaction History